Intravitreal Methotrexate and R2(Rituximab & Lenalidomide) Regimen in Newly-diagnosed Primary Vitreoretinal Lymphoma
Clinical trial NCT03746223 · UNKNOWN
Trial details
- NCT number
- NCT03746223
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2020-11-15
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.